The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure
Abstract
BACKGROUND: Much clinical research of relevance to elderly patients examines individuals who are younger than those who have the disease in question. A good example is heart failure. Therefore, we investigated the extent of exclusion of older individuals in ongoing clinical trials regarding heart failure. METHODS: In the context of the Increasing the PaRticipation of the ElDerly in Clinical Trials (PREDICT) study, data from ongoing clinical trials regarding heart failure were extracted from the World Health Organization Clinical Trials Registry Platform on December 1, 2008. Main outcome measures were the proportion of trials excluding patients by an arbitrary upper age limit or by other exclusion criteria that might indirectly cause limited recruitment of older individuals. We classified exclusion criteria into 2 categories: justified or poorly justified. RESULTS: Among 251 trials investigating treatments for heart failure, 64 (25.5%) excluded patients by an arbitrary upper age limit. Such exclusion was significantly more common in trials conducted in the European Union than in the United States (31/96 [32.3%] vs 17/105 [16.2%]; P = .007) and in drug trials sponsored by public institutions vs those by private entities (21/59 [35.6%] vs 5/36 [13.9%]; P = .02). Overall, 109 trials (43.4%) on heart failure had 1 or more poorly justified exclusion criteria that could limit the inclusion of older individuals. A similar proportion of clinical trials with poorly justified exclusion criteria was found in pharmacologic and nonpharmacologic trials. CONCLUSION: Despite the recommendations of national and international regulatory agencies, exclusion of older individuals from ongoing trials regarding heart failure continues to be widespread.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Irbesartan in patients with heart failure and preserved ejection fraction
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960
Flather, M. D., Shibata, M. C., Coats, A. J. S., Van Veldhuisen, D. J., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi115 · Cited by 1,655
Van Spall, H. G. C., Toren, A., Kiss, A., & Fowler, R. A. (2007) · JAMA · doi:10.1001/jama.297.11.1233 · Cited by 1,055
Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat, A., Gross, C. P., & Krumholz, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1682 · Cited by 723 · cited 5×
“5%) are still limiting the participation of older patients using an arbitrary upper age limit, with similar figures to those observed in 19851989, 1990-1994, and 1995-1999 (21%, 35%, and 27%, respectively).(4) Therefore, CTs that will influence clinical practice in the near future continue to discriminate against olde…”
BackgroundMethodResultInfluentialThe Exclusion of the Elderly and Women From Clinical Trials in Acute Myocardial Infarction
Gurwitz, J. H. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490110055029 · Cited by 532
Rich, M. W. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02968.x · Cited by 379
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Masoudi, F. A., Havranek, E. P., Wolfe, P., Gross, C. P., Rathore, S. S., Steiner, J. F., Ordin, D. L., & Krumholz, H. M. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00189-3 · Cited by 334
Spectrum of heart failure in older patients: Results from the national heart failure project
Havranek, E. P., Masoudi, F. A., Westfall, K. A., Wolfe, P., Ordin, D. L., & Krumholz, H. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120773 · Cited by 275
Harris, D. J., & Douglas, P. S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430706 · Cited by 255
The causes and effects of socio-demographic exclusions from clinical trials
Bartlett, C., Doyal, L., Ebrahim, S., Davey, P., Bachmann, M., Egger, M., & Dieppe, P. (2005) · Health Technology Assessment · doi:10.3310/hta9380 · Cited by 250
Bayer, A. (2000) · BMJ · doi:10.1136/bmj.321.7267.992 · Cited by 175
(2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00002 · Cited by 172
Masoudi, F. A., Havranek, E. P., & Krumholz, H. M. (2002) · Heart Failure Reviews · doi:10.1023/a:1013793621248 · Cited by 133
How to Get Older People Included in??Clinical Studies
Witham, M. D., & McMurdo, M. E. T. (2007) · Drugs & Aging · doi:10.2165/00002512-200724030-00002 · Cited by 132
O’Hare, A. M., Kaufman, J. S., Covinsky, K. E., Landefeld, C. S., McFarland, L. V., & Larson, E. B. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-10-200905190-00010 · Cited by 114
Irbesartan in patients with heart failure and preserved ejection fraction
Forman, D. E., & Gaziano, J. M. (2009) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0056-1 · Cited by 87
Selection of Patients may Limit the Generalizability of Results from Cancer Trials
Fosså, S. D., & Skovlund, E. (2002) · Acta Oncologica · doi:10.1080/028418602753669490 · Cited by 38
Badano, L. P., Lenarda, A. D., Bellotti, P., Mc, A., Sinagra, G., & Fioretti, P. M. (2003) · PubMed · Cited by 34
Hospitalization rates and length of stay for cardiovascular conditions in Canada, 1994 to 1999.
Hall, R., & Tu, J. V. (2003) · PubMed · Cited by 30
Clinical Trial Participation: Are we Studying the Patients we are Trying to Treat?
Wang, O. J., & Krumholz, H. M. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp137 · Cited by 11
Cited by
Towards a comprehensive public health response to population ageing
Beard, J. R., & Bloom, D. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61461-6 · Cited by 571
Dai, H., Much, A. A., Maor, E., Asher, E., Younis, A., Xu, Y., Lu, Y., Liu, X., Shu, J., & Bragazzi, N. L. (2022) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa076 · Cited by 315
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
Lipska, K. J., Krumholz, H., Soones, T., & Lee, S. J. (2016) · JAMA · doi:10.1001/jama.2016.0299 · Cited by 309
Nobili, A., Garattini, S., & Mannucci, P. M. (2011) · Journal of Comorbidity · doi:10.15256/joc.2011.1.4 · Cited by 300
Inclusion of older adults in the research and design of digital technology
Mannheim, I., Schwartz, E., Xi, W., Buttigieg, S. C., McDonnell-Naughton, M., Wouters, E. J. M., & van Zaalen, Y. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193718 · Cited by 291
Metadata
- Authors
- Cherubini, A., Oristrell, J., Pla, X., Ruggiero, C., Ferretti, R., Diestre, G., Clarfield, A. M., Crome, P., Hertogh, C., Lesauskaite, V., Prada, G.-I., Szczerbinska, K., Topinkova, E., Sinclair-Cohen, J., Edbrooke, D., & Mills, G. H.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2011-03-28
- Volume
- 171
- Issue
- 6
- Pages
- 550-6
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2121859696
- Cited by
- 370
- References
- 23
- FWCI
- 25.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.